Company / Free Cash Flow per Share
Fortress Biotech, Inc. Free Cash Flow per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$8.50
FY2024
5-year range
-$24.72 / -$0.90
FY2020-FY2024
Trend
+65.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share returned to growth in FY2024 after 2 years of decline, reaching $-8.50.
Based on SEC 10-K filings.
-8.50 in FY2024.
Declined from $-1.19 to $-8.50 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, free cash flow per share increased 65.6% year-over-year.
- Peak free cash flow per share was recorded in FY2016.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$8.50 | +65.6% |
| FY2023 | -$24.72 | -1970.7% |
| FY2022 | -$1.19 | -32.3% |
| FY2021 | -$0.90 | +31.4% |
| FY2020 | -$1.31 | +28.2% |
| FY2019 | -$1.83 | -13.9% |
| FY2018 | -$1.61 | -280.6% |
| FY2017 | -$0.42 | -21.9% |
| FY2016 | -$0.35 | +45.7% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026